Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line

Cancer Genetics and Cytogenetics

Volumn 147, Issue 1, 2003, Pages 28-35

  Ulger, Celal ^a   Toruner, Gokce A ^a   Alkan, Mualla ^a   Mohammed, Mansoor ^b   Damani, Shamsha ^b   Kang, Jason ^b   Galante, Anthony ^c   Aviv, Hana ^a   Soteropoulos, Patricia ^a,c   Tolias, Peter P ^a,c   Schwalb, Marvin N ^a   Dermody, James J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Spectral Genomics Inc   (United States)

^c International Center for Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GENOMIC RNA;

ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 10P; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME 9P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DATA BASE; DNA DETERMINATION; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE NUMBER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE; MONITOR; MONOSOMY X; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RNA TRANSCRIPTION; TRISOMY 18;

BACTERIA (MICROORGANISMS);

EID: 0142155150     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00155-9     Document Type: Article

References (28)

1. Heiskanen M.A., Bittner M.L., Chen Y., Khan J., Adler K.E., Trent J.M., Meltzer P.S. Detection of gene amplification by genomic hybridization to cDNA microarrays. Cancer Res. 60:2000;799-802.
2. Collins S.J., Fialkow P.J. Clonal nature of spontaneous AKR leukemia: studies utilizing the X-linked enzyme phosphoglycerate kinase. Int J Cancer. 29:1982;673-676.
3. Di Fiore P.P., Pierce J.H., Kraus M.H., Segatto O., King C.R., Aaronson S.A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 237:1987;178-182.
4. Jiang W., Kahn S.M., Tomita N., Zhang Y.J., Lu S.H., Weinstein I.B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52:1992;2980-2983.
5. Chen L.C., Neubauer A., Kurisu W., Waldman F.M., Ljung B.M., Goodson W. III, Goldman E.S., Moore D. II, Balazs M., Liu E., et al. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA. 88:1991;3847-3851.
6. Bookstein R., Lee E.Y., To H., Young L.J., Sery T.W., Hayes R.C., Friedmann T., Lee W.H. Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci USA. 85:1988;2210-2214.
7. Kauraniemi P., Barlund M., Monni O., Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res. 61:2001;8235-8240.
8. Monni O., Barlund M., Mousses S., Kononen J., Sauter G., Heiskanen M., Paavola P., Avela K., Chen Y., Bittner M.L., Kallioniemi A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA. 98:2001;5711-5716.
9. Barlund M., Monni O., Kononen J., Cornelison R., Torhorst J., Sauter G., Kallioniemi O.-P., Kallioniemi A. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. 60:2000;5340-5344.
10. Fritz B., Schubert F., Wrobel G., Schwaenen C., Wessendorf S., Nessling M., Korz C., Rieker R.J., Montgomery K., Kucherlapati R., Mechtersheimer G., Eils R., Joos S., Lichter P. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res. 62:2002;2993-2998.
11. Bayani J., Brenton J.D., Macgregor P.F., Beheshti B., Albert M., Nallainathan D., Karaskova J., Rosen B., Murphy J., Laframboise S., Zanke B., Squire J.A. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res. 62:2002;3466-3476.
12. Gallagher R., Collins S., Trujillo J., McCredie K., Ahearn M., Tsai S., Metzgar R., Aulakh G., Ting R., Ruscetti F., Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54:1979;713-733.
13. Shipley J., Weber-Hall S., Birdsall S. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 15:1996;182-186.
14. Zavadil J., Brezinova J., Svoboda P., Zemanova Z., Michalova K. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60. Leukemia. 11:1997;1187-1192.
15. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 24:2000;227-235.
16. Seo J., Kim M., Kim J. Identification of novel genes differentially expressed in PMA-induced HL-60 cells using cDNA microarrays. Mol Cells. 10:2000;733-739.
17. Zeng H. Selenite and selenomethionine promote HL-60 cell cycle progession. J Nutr. 132:2002;674-679.
18. Mitas M., Mikhitarian K., Walters C., Baron P.L., Elliott B.M., Brothers T.E., Robinson J.G., Metcalf J.S., Palesch Y.Y., Zhang Z., Gillanders W.E., Cole D.J. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 93:2001;162-171.
19. Riwald M., Chuang T., Neubauer A., Riess H., Schleef R.R. Expression of bomapin, a novel human serpin, in normal/malignant hematopoiesesis and in the monocytic cell lines THP-1 and AML 193. Blood. 91:1998;1256-1262.
20. Pinkel D., Straume T., Gray J.W. Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA. 83:1986;2934-2938.
21. Summer A.T., Evan H.J., Buckland R.A. New technique for distinguishing between human chromosomes. Nature. 232:1971;31-32.
22. Daniel W.W. Biostatistics: a foundation for analysis in health sciences. 6th edition:1995;Wiley, New York.
23. Volpi E.V., Vatcheva R., Labella T., Gan S.U. More detailed characterization of some of the HL60 karyotypic features by fluorescence in situ hybridization. Cancer Genet Cytogenet. 87:1996;103-106.
24. Alizadeh A.A., Ross D.T., Perou C.M., van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol. 195:2001;41-52.
25. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
26. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 98:2001;10869-10874.
27. Li S., Ross D.T., Kadin M.E., Brown P.O., Wasik M.A. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol. 158:2001;1231-1237.
28. Dales J.P., Plumas J., Palmerini F., Devilard E., Defrance T., Lajmanovich A., Pradel V., Birg F., Xerri L. Correlation between apoptosis microarray gene expression profiling and histopathological lymph node lesions. Mol Pathol. 54:2001;17-23.